The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Lapatinib-based therapy for women with advanced/metastatic HER2+ breast cancer.
Jamal M Zekri
No relevant relationships to disclose
Meteb Owaish Al-Foheidi
No relevant relationships to disclose
Mohamed Mokhtar Ibrahim
No relevant relationships to disclose
Tarek Darwish
No relevant relationships to disclose
Mervat Mahrous
No relevant relationships to disclose
Maged Mansour
No relevant relationships to disclose
Azhar J Rizvi
No relevant relationships to disclose
Turki Mohammad Al Fayea
No relevant relationships to disclose